You can follow our portfolio and take advantage of it. Our portfolio is not a buy recommendation.

November 20, 2026

Analyses

Buying More Is the Best Cure for an AI Hangover!

In our opinion, this company receives far too little recognition for its opportunities in artificial intelligence, yet its shares have suffered alongside the broader market during the recent sell-off. At approximately €3.20, we see an attractive opportunity to increase our position. After all, we believe there is considerably more potential beneath the surface than the…

Read more >
Analyses

After the Share Price Collapse, We’re Hunting for an Opportunity

Buying shares in a company that has just suffered a sharp decline can feel a little like disaster tourism. Nevertheless, we are taking a closer look at what the recent sell-off has left behind at Haleon. Its strong portfolio of consumer brands and impressive cash generation have caught our attention, although disappointing volume growth and…

Read more >

Join thousands of others?

from Β£20.99 per month

Become a member now and get instant access to our entire platform.Β 

The value we offer:

Small investment, big potential

Our analysts constantly search for and find the most promising stocks under ten of the moment